跳至主要内容
临床试验/NCT01781624
NCT01781624已完成不适用

Evaluation of an Oral Nutritional Supplement With a New Protein Blend

Abbott Nutrition2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2012年10月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
2
主要终点
Gastro-Intestinal Tolerance

研究概览

简要总结

The objective of this study is to evaluate gastrointestinal tolerance of an oral nutritional supplement containing a new protein blend in healthy elderly subjects.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
盲法
None

入排标准

年龄范围
60 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects will be eligible for the study if they meet all of the following inclusion criteria:
  • Age ≥ 60 and ≤ 90 years
  • Body Mass Index (BMI) > 20 but < 35

排除标准

  • Subjects will be excluded from the study if they meet any of the following criteria:
  • History of diabetes
  • Currently taking or has taken antibiotic within 1 week prior to enrollment
  • Major surgery less than 3 months prior to enrollment in the study
  • Current active malignant disease or was treated within the last 6 months for cancer
  • Immunodeficiency disorder
  • Myocardial infarction within the last 3 months prior to enrollment
  • Chronic obstructive pulmonary disease (COPD)
  • Allergy to any of the ingredients in the study product
  • Aversion to flavor of product being tested
  • Obstruction of the gastrointestinal tract precluding ingestion or absorption of the study product, inflammatory bowel disease, ulcer, gastric reflux disease, short bowel syndrome, or other major gastrointestinal disease
  • Dementia, brain metastases, eating disorders, history of significant neurological or psychiatric disorder
  • Pursuing or has unintentional weight loss or weight gain ≥ 5% in last 4 weeks
  • Medications/dietary supplements/substances that could profoundly modulate metabolism or affect GI motility

研究组 & 干预措施

Study Oral Nutritional Supplement

Experimental

2 containers a day of a high calorie, complete, balanced, ready-to-drink oral nutritional supplement with a new protein blend.

干预措施: Study Oral Nutritional Supplement (Other)

结局指标

主要结局

Gastro-Intestinal Tolerance

时间窗: Study Day 1-7

Self-reported questionnaire

次要结局

  • Weight(Study Day 1 and 8)
  • Study Product Compliance(Study Day 1-7)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Evaluation of an Oral Nutritional Supplement | 临床试验